Toxys launches large international validation study for ToxTracker
Leiden, 1 May 2017 - Together with a consortium of leading experts in the field of genotoxicity, Toxys has started a large inter-laboratory validation study for their ToxTracker assay. With this study, Toxys aims to demonstrate the transferability, intra- and inter-laboratory reproducibility as well as the predictive capacity of the assay. In 2015, a preliminary inter-laboratory validation study already indicated an excellent transferability and reproducibility. Now, in a large international validation study, together with seven expert laboratories, Toxys is determined to confirm the outstanding performance and added value of the ToxTracker assay. The validation study is initiated in parallel to the recent initiatives towards the European Center for Validation of Alternative Methods (ECVAM) and the Organisation for Economic Cooperation and Development (OECD) and should contribute to regulatory acceptance of the ToxTracker assay.
ToxTracker presented in webinar by Charles River about genotoxicity testing: Avoid Program Set-Backs: Deciphering Positive Responses link to webinar
Toxys is part of the organising committee for the GTTC Mode of Action workshop at the annual meeting of the American Genetic Toxicology Association (May 10th 2017) Click for more information
Toxys mentioned as top-10 Biotech in Leiden In this article by Labiotech.eu Toxys is mentioned as one of the top-10 biotech companies in Leiden.
Opportunities to get in contact
We will attend and give presentations at several conferences this year. We are more than happy to meet alongside any of these meetings. If you are interested to learn more about our unique assays we could also schedule a TC to take you to a presentation on the assay.
